Introduction
It is estimated that oropharyngeal cancer makes up to 3% of all newly diagnosed carcinomas, with majority of cases occurring in developing countries.
1.2 Although common risk factors are preventable and most of the cases are easily diagnosed by a standard oral exam, due to a huge lack of awareness, disease is usually detected in the advance stages.
3
In the past decade, patient's quality of life (QOL) and functioning after the treatment has become an important additional tool of assessing the treatment outcome of oral cavity and oropharyngeal cancer. 4 A number of recent studies assessed quality of life in patients with both entities combined, but it should be considered that oropharynx and oral cavity are two different anatomical sites, each with its own specific anatomy and functions. Oropharyngeal region includes following sub-sites: base of tongue, tonsil, and oropharynx, opposing to oral cavity region which includes lip, oral tongue, floor of mouth and gums, palate or other sections of the mouth. This distinctions became more important in light of the new patterns noticed in etiology and incidence trends. First, there is a distinct increase in the incidence of oropharyngeal cancer with the decrease in the incidence of oral cavity cancers. 5, 6 In the United States, tonsillar cancer showed to be most frequent diagnosed oropharyngeal cancer. Second most frequent diagnosed site was base of the tongue.Both sites showed increasing incidence during a period from 2000 to 2010 comparing to the trends for other anatomic sites of the oral cavity and oropharynx. 6 Secondly, a shift in age of diagnosis has happened, making 6 th and 7 th decade of life high risk period for oropharyngeal cancer compared to oral cavity cancer. 6, 7 Thirdly, epidemiology of oropharyngeal cancer changed, with risk-factors like smoking and alcohol replaced with Human Papilloma Virus (HPV) infection. Oropharyngeal cancer caused with HPV occur in different population to that commonly associated with head and neck cancers, with significantly better prognosis than HPV negative cancers. 8 These trends are forcing us to further narrow our focus on better treatment choices for oropharyngeal cancer, and post-treatment quality of life in specific groups of patients. Patients with oropharyngeal cancer confront substantial QOL issues after successful cancer management. 9 Depending on the sociodemographic characteristic, choice of the treatment and stage of the disease, going back to regular diet, performing usual everyday tasks and professional duties requires a significant effort in these patients.
The aim of this study was to assess the impact of different demographical data, HPV status, stage of disease, and treatment type on quality of life and functional performance in patients with oropharyngeal cancer with successfully achieved locoregional control a year after the treatment. Surgical therapy involved resection of the tumor (local resection or hemiglossectomy) with some form of neck dissection in case of cervical lymphadenopathy. Radiotherapy consisted of external radiotherapy with total dose of 60 to 70Gy in 30-35 fractions for 6-7 weeks.
Material and methods

Cross
Patients received chemotherapy concurrently with radiotherapy; three courses of cisplatin (CDDP) intravenously, on 1 st , 4 th and 7 th week of radiotherapy. In patients who were disease-free, quality of life and functional impairment assessment was conducted 12 to 14 months after finished oncological treatment. Patients with recurrent disease were excluded from the study.
For assessing the quality of life two types of questionnaires were used: the Statistical analysis was performed using SPSS v20 (SPSS Inc., Chicago, IL). To determine differences between examined groups of patients, depending on investigated parameters, T test and ANOVA were used. Pearson's correlation test was used to determine the correlation between EORTC QLQ-C30, EORTC QLQ-H&N35 and KPS Index scores and other parameters. P-value less than 0.05 was considered statistically significant.
Results
The study included 87 patients (69 males and 18 females) of an average age of Most of the parameters of QOL, when assessed post-treatment are at the lowest 3 months after treatment 17 , but one year post-treatment major improvements in scores happen in disease free head and neck patients. 19, 20 The assessment of QOL parameters in our study was done in that period, which is considered to be a good time for assessment of QOL, because most of QLQ-C30 and QLQ-H&N35 scores are returning to preoperative values, depending on the treatment 21 , and variations are considered negligible in the absence of recurrent disease.
22
During this study, demographic and social factors significantly influenced QOL and functional performance in patients with oropharyngeal cancer, in addition to stage of the disease and treatment modality. This results were already proven to be significant.
23,24
Considering the different oropharyngeal sub sites involved, treatment is associated with wide range of functional and psychosocial deficits. Multiple QOL segments are influenced, and patients are forced to make permanent changes in their eating habits, swallowing, appearance and communication. It is reasonable to expect differences in QOL between patients treated of oropharyngeal carcinoma depending their age, marital and educational status and employment. In this study women had significantly worse scores in many aspects of functioning, and also regarding fatigue, dyspnea, insomnia, and appetite loss, senses, contact and sexuality, making gender significant factor which influences QOL scores in these patients. Marital status influenced limited aspects of QOL, mostly emotional and cognitive functioning, sexual life and felling ill. There were significant differences noted in patients living in rural areas; they had fewer problems with the senses, dry mouth, felt less nauseous and dyspneic, than those living in urban areas. There are studies that noted the differences in emotional, functional, and HNC-specific scores between head and neck cancer survivors living in rural and urban areas, in term of better QOL in rural areas.
25
Level of education significantly influenced some QOL aspects, like global quality of life and cognitive functioning, nausea, dyspnea, appetite loss, swallowing, eating and feeling ill. This was generally noticed in patients with head and neck carcinoma. and have more trouble in adaptation to other work positions. 26 Considering the structure of patients in our study, with 83.8% with high-school education and lower and 44% working s laborers, these claims are highly applicable.
The relation between HPV and QOL was explored in a few studies. Sharma et al.
found no association between HPV status and QOL one year post-treatment. 27 On the other hand, Maxwell et al. 30 published that HPV positive patients had significantly better scores considering activity, recreation, swallowing, chewing, speech and overall quality of life a year after the treatment. Production of saliva in HPV positive was poorer comparing to HPV negative patients in first 12 months, but after that time, difference was no longer significant. A year after the treatment, HPV positive patients in our study complained significantly less of pain, dyspnea and on trouble with their senses. Global QOL was better in HPV positive patients, but differences weren't significant. Due to favorable reaction to radiotherapy and better survival rates, we could argue that HPV positivity surely influences postoperative QOL in patients with oropharyngeal carcinoma. Recommended modality treatment depending on HPV status would certainly be a subject for further discussion, with more knowledge accumulated on the subject. 36, 37 In our study there were some differences in functional aspects (eating, swallowing, complaints of dry mouth and saliva production), but insignificant between groups of patients considering the treatment modality. Our findings could have been strongly influenced by the time of evaluation.
Differences between QOL scores in patients treated with different treatment modalities proved to be greatest three months after the treatment, and by 6 and 12 months of follow-up were significantly less pronounced. There are some limitations of the study. First, the study assessed quality of life and functional performance in patients with oropharyngeal cancer at a time point, not prospectively, so any changes between the influence of sociodemographic factors and quality of life over time wasn't followed. Second, the number of patients in the study was small, and the results of this study should be evaluated cautiously. Last, number of patients with different sub sites of the oropharyngeal carcinoma was also small and wasn't analyzed how different oropharyngeal sub sites involvement influenced quality of life and functional performance.
Conclusion
Clinicians should take in mind socioeconomic factors and HPV status planning recovery course after treatment in patients with oropharyngeal carcinoma. Gender, education level and employment are variables that form certain risk profiles associated with lower post-treatment QOL. This would ultimately lead to better functional results, faster recovery and return to everyday life and activities in patients with oropharyngeal cancer. 
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